Answer
Yes, tocilizumab (RoActemra) is contraindicated in active, severe infections other than COVID-19.
Sources for this answer
- RoActemra 20mg/ml Concentrate for Solution for InfusionRoche Products Limited · emc · SmPC §4.3 Contraindications · Version 38Document updated
Sources checked